[3-[8-(4-chlorophenyl)-3H-pyrazolo[4,5-f]quinolin-7-yl]-2-methoxyphenyl]boronic acid
C23H17BClN3O3 — CID 155511624
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-[8-(4-chlorophenyl)-3H-pyrazolo[4,5-f]quinolin-7-yl]-2-methoxyphenyl]boronic acid
[3-[8-(4-chlorophenyl)-3H-pyrazolo[4,5-f]quinolin-7-yl]-2-methoxyphenyl]boronic acid (PubChem CID 155511624) has the molecular formula C23H17BClN3O3 and a molecular weight of 429.67 g/mol. Its IUPAC name is [3-[8-(4-chlorophenyl)-3H-pyrazolo[4,5-f]quinolin-7-yl]-2-methoxyphenyl]boronic acid.
Molecular Properties
| Compound Name | [3-[8-(4-chlorophenyl)-3H-pyrazolo[4,5-f]quinolin-7-yl]-2-methoxyphenyl]boronic acid |
|---|---|
| PubChem CID | 155511624 |
| Molecular Formula | C23H17BClN3O3 |
| Molecular Weight | 429.67 g/mol |
| Exact Mass | 429.11 |
| IUPAC Name | [3-[8-(4-chlorophenyl)-3H-pyrazolo[4,5-f]quinolin-7-yl]-2-methoxyphenyl]boronic acid |
| SMILES | COc1c(B(O)O)cccc1-c1nc2ccc3[nH]ncc3c2cc1-c1ccc(Cl)cc1 |
| InChI | InChI=1S/C23H17BClN3O3/c1-31-23-15(3-2-4-19(23)24(29)30)22-16(13-5-7-14(25)8-6-13)11-17-18-12-26-28-21(18)10-9-20(17)27-22/h2-12,29-30H,1H3,(H,26,28) |
| InChIKey | UVLPFHOKQGIMJZ-UHFFFAOYSA-N |
| XLogP | 3.79 |
| TPSA | 91.26 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.67 |
| LogP ≤ 5 | 3.79 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155511624 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.